Trends in prescriptions of valproate and valpromide for bipolar disorder in IMS France and IMS Germany between 2010 and June 2016 and in UK THIN between 1999 and 2015

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/44731
• EU PAS number:
  EUPAS19162
• Study ID:
  44731
• Official title and acronym:
  Trends in prescriptions of valproate and valpromide for bipolar disorder in IMS France and IMS Germany between 2010 and June 2016 and in UK THIN between 1999 and 2015
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany

  United Kingdom
• Study description:
  This study will provide drug utilisation data on valproate prescribing among the general population using data from France, Germany and the UK.
• Study status:
  Finalised

Research institution and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 03/01/2017

Actual: 03/01/2017

Study start date

Planned: 03/01/2017

Actual: 03/01/2017

Data analysis start date

Planned: 03/01/2017

Actual: 09/01/2017

Date of final study report

Planned: 31/08/2017

Actual: 06/06/2017

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable